Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/35654
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3646]
Metadata
Show full item record
TORUS PALATINUS OSTEONECROSIS RELATED TO BISPHOSPHONATE: A CASE REPORT
Affilliation
Federal University of Rio de Janeiro. Sector of Dermatology. University Hospital. Rio de Janeiro, RJ, Brazil / Federal University of Rio de Janeiro. School of Medicine. Rio de Janeiro, RJ, Brazil.
Fabio Barbosa Dermatology Clinic. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Sector of Dermatology. University Hospital. Rio de Janeiro, RJ, Brazil / Federal University of Rio de Janeiro. School of Medicine. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Sector of Pathology. University Hospital. Rio de Janeiro, RJ, Brazil / Federal University of Rio de Janeiro. School of Medicine. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Sector of Dermatology. University Hospital. Rio de Janeiro, RJ, Brazil / Federal University of Rio de Janeiro. School of Medicine. Rio de Janeiro, RJ, Brazil.
Fabio Barbosa Dermatology Clinic. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Sector of Dermatology. University Hospital. Rio de Janeiro, RJ, Brazil / Federal University of Rio de Janeiro. School of Medicine. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Sector of Pathology. University Hospital. Rio de Janeiro, RJ, Brazil / Federal University of Rio de Janeiro. School of Medicine. Rio de Janeiro, RJ, Brazil.
Federal University of Rio de Janeiro. Sector of Dermatology. University Hospital. Rio de Janeiro, RJ, Brazil / Federal University of Rio de Janeiro. School of Medicine. Rio de Janeiro, RJ, Brazil.
Abstract
Introduction: Osteonecrosis of the palate is a rare condition which is even rarer when occurring on a torus palatinus and associated with bisphosphonate (BP). Case Presentation: We report an uncommon case of osteonecrosis of a torus palatinus. Our patient was a 67-year-old white female who presented with a painful intraoral ulcer associated with necrotic bone tissue of her torus palatinus, due to the chronic use of alendronate. Conclusion: We point out the possible causative relationship of BPs and osteonecrosis on torus growth. It is very important to know that torus palatinus and the use of BPs are risk factors for osteonecrosis of the maxilla.
Share